NCT01898650

Brief Summary

Craniosynostosis is a birth defect that causes the bones on a baby's head to fuse together earlier than normal. This causes the baby to have an abnormally shaped head. These children are operated on to prevent or treat increased pressure on the brain, allowing for normal development. There is not good evidence of which children with craniosynostosis have increased pressure on the brain. Up to twenty patients with craniofacial abnormalities will be enrolled in this pilot study. The investigators will use a magnetic resonance scanner to obtain several measures of brain metabolism. The investigators will also obtain data which are markers of developmental delay. The results will also be compared to age and gender matched data from children without craniofacial abnormalities. There study hypothesis is that patients with craniofacial abnormalities associated with intracranial pressure will have decreased metabolic activity compared to control patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

January 30, 2013

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 12, 2013

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
5.6 years until next milestone

Results Posted

Study results publicly available

February 1, 2023

Completed
Last Updated

May 23, 2023

Status Verified

May 1, 2023

Enrollment Period

4.4 years

First QC Date

December 6, 2012

Results QC Date

November 30, 2021

Last Update Submit

May 19, 2023

Conditions

Keywords

craniosynostosissagittal synostosismetopic synostosiscoronal synostosislambdoid synostosis

Outcome Measures

Primary Outcomes (1)

  • Blood Flow and Perfusion

    To be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.

    during the single MRI scan, approximately 30 - 45 minutes

Study Arms (1)

craniofacial abnormalities

EXPERIMENTAL

Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan.

Other: MR scan

Interventions

MR scanOTHER
craniofacial abnormalities

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients presenting to the Plastic Surgery or Neurosurgery clinics with scheduled sedated MRI and abnormalities such as hydrocephalus (and possibly some patients to be used as controls who present to the clinic with no known skull or brain abnormalities)

You may not qualify if:

  • history of abnormalities known to affect brain topology or function
  • implants (e.g. pacemakers) that might rule out use of MR scanning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Louis Children's Hospital

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Craniosynostoses

Condition Hierarchy (Ancestors)

SynostosisDysostosesBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Limitations and Caveats

A primary limitation of this study is the small sample size and the variability between subjects with respect to their diagnosis and condition.

Results Point of Contact

Title
Gary Skolnick
Organization
Washington University School of Medicine

Study Officials

  • Kamlesh Patel, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: individual participants will serve as their own controls by using affected and unaffected regions of the brain for paired analysis
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2012

First Posted

July 12, 2013

Study Start

January 30, 2013

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

May 23, 2023

Results First Posted

February 1, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations